{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:57:23Z","timestamp":1784901443751,"version":"3.55.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1053\/j.semnuclmed.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T23:23:35Z","timestamp":1591572215000},"page":"434-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer"],"prefix":"10.1053","volume":"50","author":[{"given":"Farshad","family":"Moradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Iagaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0001","first-page":"132","article-title":"Which is the Best Imaging Method in Pancreatic Adenocarcinoma Diagnosis and Staging - CT, MRI or EUS?","volume":"43","author":"Costache","year":"2017","journal-title":"Curr Health Sci J"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: Version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0003","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1148\/radiol.2243011284","article-title":"Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: Secondary signs","volume":"224","author":"Prokesch","year":"2002","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jmri.24523","article-title":"Integrated PET\/MR","volume":"39","author":"Quick","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.2016152798","article-title":"Preoperative Assessment of Pancreatic Cancer with FDG PET\/MR Imaging versus FDG PET\/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study","volume":"282","author":"Joo","year":"2017","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00259-019-04452-y","article-title":"PET\/MRI versus PET\/CT in oncology: A prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations","volume":"47","author":"Mayerhoefer","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0007","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ije\/dyx232","article-title":"Pancreatic cancer incidence trends: Evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data","volume":"47","author":"Gordon-Dseagu","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0008","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5152\/dir.2018.17250","article-title":"Pancreas ductal adenocarcinoma with cystic features on cross-sectional imaging: Radiologic-pathologic correlation","volume":"24","author":"Youn","year":"2018","journal-title":"Diagn Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0010","doi-asserted-by":"crossref","first-page":"e17175","DOI":"10.1097\/MD.0000000000017175","article-title":"Emerging incidence trends and application of curative treatments of pancreatic cancer in the USA","volume":"98","author":"Pei","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0011","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3892\/mco.2013.131","article-title":"Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival","volume":"1","author":"Tas","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0012","first-page":"603","article-title":"NCCN Guidelines Updates: Pancreatic Cancer","volume":"17","author":"Tempero","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/pancan.2017.0014","article-title":"Incremental Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography in the Assessment of Computed Tomography-Inconspicuous Pancreatic Lesions","volume":"3","author":"Ahmad Saad","year":"2017","journal-title":"J Pancreat Cancer"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0014","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/RLU.0000000000002665","article-title":"Incidental Detection of Adenocarcinoma in the Neck of the Pancreas by FDG PET Imaging When a Cystic Lesion in the Body of Pancreas Was Evaluated","volume":"44","author":"Xing","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/RLU.0000000000001537","article-title":"Pancreatic Cancer Complicated by Pancreatitis Demonstrated on FDG PET\/CT","volume":"42","author":"Hennessy","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MPA.0000000000001456","article-title":"Characteristic Radiological Features of Retrospectively Diagnosed Pancreatic Cancers","volume":"49","author":"Fukushima","year":"2020","journal-title":"Pancreas"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11307-006-0075-y","article-title":"Standardized uptake value atlas: Characterization of physiological 2-deoxy-2-[18F]fluoro-D-glucose uptake in normal tissues","volume":"9","author":"Wang","year":"2007","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0018","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3892\/or.2017.5479","article-title":"Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism","volume":"37","author":"Shan","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0019","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41419-018-0486-0","article-title":"Tumor-associated macrophages promoteprogression and the Warburg effect via CCL18\/NF-kB\/VCAM-1 pathway in pancreatic ductal adenocarcinoma","volume":"9","author":"Ye","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0020","doi-asserted-by":"crossref","first-page":"e32996","DOI":"10.1371\/journal.pone.0032996","article-title":"Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma","volume":"7","author":"Chaika","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0021","doi-asserted-by":"crossref","first-page":"19760","DOI":"10.18632\/oncotarget.15035","article-title":"Prognostic value of GLUT-1 expression in pancreatic cancer: Results from 538 patients","volume":"8","author":"Sharen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0022","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3892\/ol.2016.4586","article-title":"Expression and clinical significance of glucose transporter-1 in pancreatic cancer","volume":"12","author":"Lu","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217781","article-title":"Associations between GLUT expression and SUV values derived from FDG-PET in different tumors-A systematic review and meta analysis","volume":"14","author":"Meyer","year":"2019","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0024","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1245\/s10434-017-5799-1","article-title":"Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer","volume":"24","author":"Chikamoto","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0025","doi-asserted-by":"crossref","first-page":"E4111","DOI":"10.1073\/pnas.1511698112","article-title":"Functional expression of sodium-glucose transporters in cancer","volume":"112","author":"Scafoglio","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0026","article-title":"Does 2-FDG-PET Accurately Reflect Quantitative In vivo Glucose Utilization?","author":"Barrio","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0027","doi-asserted-by":"crossref","first-page":"95361","DOI":"10.18632\/oncotarget.20545","article-title":"Endogenous glutamine decrease is associated with pancreatic cancer progression","volume":"8","author":"Roux","year":"2017","journal-title":"Oncotarget"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0028","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0029","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm.4256","article-title":"Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors","volume":"23","author":"Davidson","year":"2017","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","article-title":"Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein","volume":"75","author":"Kamphorst","year":"2015","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00280-017-3477-4","article-title":"Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma","volume":"81","author":"Altan","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0032","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/his.12464","article-title":"Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma","volume":"66","author":"Kaira","year":"2015","journal-title":"Histopathology"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0033","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.amjsurg.2014.06.038","article-title":"Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography imaging in pancreatic ductal adenocarcinoma patients with diabetes","volume":"209","author":"Chung","year":"2015","journal-title":"Am J Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213202","article-title":"Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls","volume":"14","author":"Bakker","year":"2019","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0035","doi-asserted-by":"crossref","first-page":"e16429","DOI":"10.5812\/ijem.16429","article-title":"Impact of Plasma Glucose Level at the Time of Fluorodeoxyglucose Administration on the Accuracy of FDG-PET\/CT in the Diagnosis of Pancreatic Lesions","volume":"12","author":"Hamidian Jahromi","year":"2014","journal-title":"Int J Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jgh.12068","article-title":"Role of (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in the characterization of pancreatic masses: Experience from tropics","volume":"28","author":"Santhosh","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0037","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00261-014-0266-y","article-title":"Metabolic signatures of malignant and non-malignant mass-forming lesions in the periampulla and pancreas in FDG PET\/CT scan: An atlas with pathologic correlation","volume":"40","author":"Santhosh","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0038","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MNM.0b013e328360668a","article-title":"Role of SUV(max) obtained by 18F-FDG PET\/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation","volume":"34","author":"Hu","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0039","first-page":"452","article-title":"Diagnosis of pancreatic cancer using (1)(8)F-FDG PET\/CT and CA19-9 with SUVmax association to clinical characteristics","volume":"20","author":"Sun","year":"2015","journal-title":"J buon"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0040","article-title":"Imaging modalities for characterising focal pancreatic lesions","volume":"4","author":"Best","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0041","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejso.2014.03.016","article-title":"Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis","volume":"40","author":"Rijkers","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0042","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00000658-199905000-00016","article-title":"18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer","volume":"229","author":"Rose","year":"1999","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22070","volume":"22","author":"Ghaneh","year":"2018","journal-title":"Health Technol Assess"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0044","first-page":"159","article-title":"Role of (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography","volume":"33","author":"Ergul","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0045","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.3748\/wjg.v21.i10.2988","article-title":"Cross-modality PET\/CT and contrast-enhanced CT imaging for pancreatic cancer","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0046","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12149-013-0719-3","article-title":"The usefulness of (18)F-FDG PET\/MRI fusion image in diagnosing pancreatic tumor: Comparison with (18)F-FDG PET\/CT","volume":"27","author":"Nagamachi","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0047","doi-asserted-by":"crossref","first-page":"e7813","DOI":"10.1097\/MD.0000000000007813","article-title":"Prognostic value of 18F-FDG-PET\/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis","volume":"96","author":"Zhu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0048","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11605-017-3627-3","article-title":"18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma","volume":"22","author":"Ariake","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0049","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12885-019-5691-4","article-title":"Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma","volume":"19","author":"Gu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0050","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2214\/AJR.14.13156","article-title":"Prognostic Value of FDG PET\/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET\/CT Staging","volume":"204","author":"Chirindel","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0051","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12149-014-0833-x","article-title":"Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer","volume":"28","author":"Ahn","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0052","doi-asserted-by":"crossref","first-page":"e2595","DOI":"10.1097\/MD.0000000000002595","article-title":"Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer","volume":"95","author":"Kang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0053","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5009\/gnl18242","article-title":"Preoperative Metabolic Tumor Volume2.5 Associated with Early Systemic Metastasis in Resected Pancreatic Cancer: A Transcriptome-Wide Analysis","volume":"13","author":"Lee","year":"2019","journal-title":"Gut Liver"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0054","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijrobp.2014.02.031","article-title":"Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy","volume":"89","author":"Dholakia","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0055","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00259-017-3755-8","article-title":"Heterogeneity index evaluated by slope of linear regression on (18)F-FDG PET\/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma","volume":"44","author":"Kim","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0056","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.3617","article-title":"International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer","volume":"153","author":"van Roessel","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0057","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MPA.0000000000001233","article-title":"Comparative Accuracy of Tumor Size Assessment and Stage Analysis by Imaging Modalities Versus Gross Examination for Pancreatic Ductal Adenocarcinoma","volume":"48","author":"Kassardjian","year":"2019","journal-title":"Pancreas"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0058","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140590","article-title":"Consequences of additional use of contrast-enhanced (18)F-FDG PET\/CT in target volume delineation and dose distribution for pancreatic cancer","volume":"88","author":"Li","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0059","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2967\/jnumed.108.051466","article-title":"Contrast-enhanced 18F-FDG PET\/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer","volume":"49","author":"Strobel","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","article-title":"Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer","volume":"261","author":"Ferrone","year":"2015","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0061","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijsu.2017.09.003","article-title":"Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis","volume":"46","author":"Wang","year":"2017","journal-title":"Int J Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0062","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/SLA.0b013e3181b2fafa","article-title":"A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer","volume":"250","author":"Kauhanen","year":"2009","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0063","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MPA.0b013e3182550d77","article-title":"Utility of contrast-enhanced FDG-PET\/CT in the clinical management of pancreatic cancer: Impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence","volume":"42","author":"Asagi","year":"2013","journal-title":"Pancreas"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0064","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12149-017-1193-0","article-title":"Fluorodeoxyglucose-positron emission tomography\/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma","volume":"31","author":"Santhosh","year":"2017","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"Isaji","year":"2018","journal-title":"Pancreatology"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0066","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1445-5994.2010.02257.x","article-title":"18 F-FDG PET\/CT influences management in patients with known or suspected pancreatic cancer","volume":"41","author":"Barber","year":"2011","journal-title":"Intern Med J"},{"issue":"Suppl 7","key":"10.1053\/j.semnuclmed.2020.04.002_bib0067","doi-asserted-by":"crossref","first-page":"vii33","DOI":"10.1093\/annonc\/mds224","article-title":"Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Seufferlein","year":"2012","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"10.1053\/j.semnuclmed.2020.04.002_bib0068","doi-asserted-by":"crossref","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","article-title":"Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0069","unstructured":"National Comprehensive Cancer Network (2019) Pancreatic Adenocarcinoma (Version 3.2019)."},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0070","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0071","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00261-018-1765-z","article-title":"Detection of recurrent pancreatic cancer: value of second-opinion interpretations of cross-sectional images by subspecialized radiologists","volume":"44","author":"Huicochea Castellanos","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0072","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11605-009-1010-8","article-title":"Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT","volume":"14","author":"Sperti","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0073","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00261-017-1316-z","article-title":"Utility of (18) F-FDG PET\/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma","volume":"43","author":"Rayamajhi","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0074","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejrad.2018.07.010","article-title":"The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: A systematic review and meta-analysis","volume":"106","author":"Daamen","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00535-003-1244-2","article-title":"Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer","volume":"39","author":"Yoshioka","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0076","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.tranon.2018.06.011","article-title":"PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study","volume":"11","author":"Dalah","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0077","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ejso.2017.03.015","article-title":"FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer","volume":"43","author":"Akita","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0078","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejrad.2017.05.021","article-title":"Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography\/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma","volume":"94","author":"Sakane","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0079","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MNM.0000000000000436","article-title":"18F-FDG-PET\/CT therapy assessment of locally advanced pancreatic adenocarcinoma: Impact on management and utilization of quantitative parameters for patient survival prediction","volume":"37","author":"Sheikhbahaei","year":"2016","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/0284186X.2016.1256497","article-title":"Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy","volume":"56","author":"Mellon","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0081","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jhbp.430","article-title":"Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response in patients with borderline resectable pancreatic carcinoma","volume":"24","author":"Okada","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0082","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jjco\/hyy033","article-title":"18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer","volume":"48","author":"Okano","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0083","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-017-0125-5","article-title":"(18)F-FDG PET\/CT response in a phase 1\/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer","volume":"17","author":"Korn","year":"2017","journal-title":"Cancer Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0084","article-title":"Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas","volume":"2017","author":"Pompa","year":"2017","journal-title":"Case Rep Oncol Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0085","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2214\/AJR.18.19602","article-title":"Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET\/MRI","volume":"211","author":"Wang","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0086","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2967\/jnumed.119.226407","article-title":"Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study","volume":"61","author":"Yoo","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0087","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1158\/1078-0432.CCR-17-0664","article-title":"(89)Zr-anti-gammaH2AX-TAT but not (18)F-FDG Allows Early Monitoring of Response to Chemotherapy in a Mouse Model of Pancreatic Ductal Adenocarcinoma","volume":"23","author":"Knight","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0088","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.clon.2017.01.038","article-title":"Correlation of (18)F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy","volume":"29","author":"Wilson","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0089","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12885-018-4469-4","article-title":"PET\/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms","volume":"18","author":"Moletta","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0090","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.radcr.2019.04.004","article-title":"Two rare cases of pancreatic adenosquamous carcinoma: A review of the literature with focus on radiologic findings","volume":"14","author":"Cedeno Kelly","year":"2019","journal-title":"Radiol Case Rep"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0091","doi-asserted-by":"crossref","first-page":"e7904","DOI":"10.1097\/MD.0000000000007904","article-title":"Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement: Two case reports and literature review","volume":"96","author":"Luo","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0092","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40792-016-0263-1","article-title":"A mixed adenoneuroendocrine carcinoma of the pancreas: A case report","volume":"2","author":"Imaoka","year":"2016","journal-title":"Surg Case Rep"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0093","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.surg.2018.11.006","article-title":"Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas","volume":"165","author":"Srinivasan","year":"2019","journal-title":"Surgery"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0094","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2967\/jnumed.114.148940","article-title":"Accuracy of 18F-FDG PET\/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study","volume":"56","author":"Kauhanen","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IJGC:28:2:097","article-title":"Preoperative diagnosis of pancreatic leiomyosarcoma","volume":"28","author":"Machado","year":"2000","journal-title":"Int J Pancreatol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0096","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1097\/RLU.0000000000001822","article-title":"Pancreatoblastoma With Metastatic Retroperitoneal Lymph Node and PET\/CT","volume":"42","author":"Corrias","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0097","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/RLU.0000000000000584","article-title":"Primary pancreatic choriocarcinoma revealed on FDG PET\/CT","volume":"40","author":"Rao","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviscsurg.2020.01.006","article-title":"The value of (18)F-FDG positron emission tomography to differentiate benign from malignant intraductal papillary mucinous neoplasms: A prospective multicenter study","author":"Regenet","year":"2020","journal-title":"J Visc Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0099","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s11605-019-04113-3","article-title":"Natural History and Treatment Trends in Pancreatic Cancer Subtypes","volume":"23","author":"Pokrzywa","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0100","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/MPA.0000000000001424","article-title":"Investigation of Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas: A Study Associated With a National Survey of Solid Pseudopapillary Neoplasms","volume":"48","author":"Kurihara","year":"2019","journal-title":"Pancreas"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0101","doi-asserted-by":"crossref","first-page":"286","DOI":"10.14701\/ahbps.2019.23.3.286","article-title":"A case of pancreatic hamartoma pathologically confirmed after robot-assisted pancreaticoduodenectomy","volume":"23","author":"Shin","year":"2019","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0102","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12876-017-0704-8","article-title":"A small pancreatic hamartoma with an obstruction of the main pancreatic duct and avid FDG uptake mimicking a malignant pancreatic tumor: a systematic case review","volume":"17","author":"Nagano","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0103","doi-asserted-by":"crossref","first-page":"e5570","DOI":"10.1097\/MD.0000000000005570","article-title":"Granulocytic sarcoma of the pancreas on 18F-FDG PET\/CT: A case report","volume":"95","author":"Ishii","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/RLU.0000000000001901","article-title":"Focal Autoimmune Pancreatitis Mimicking Pancreatic Cancer on FDG PET\/CT Imaging","volume":"43","author":"Zheng","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s12885-017-3665-y","article-title":"(18)F- FDG PET\/CT helps differentiate autoimmune pancreatitis from pancreatic cancer","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0106","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinimag.2019.08.006","article-title":"Follicular pancreatitis: A rare pancreatic inflammatory pseudotumor","volume":"59","author":"Tom","year":"2020","journal-title":"Clin Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0107","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/RLU.0000000000001357","article-title":"High Uptake of FDG Along a Biliary Stent","volume":"41","author":"Nagasaki","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4251\/wjgo.v8.i2.165","article-title":"Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals","volume":"8","author":"Xu","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.prro.2017.09.008","article-title":"Pilot study on the impact of F18-labeled thymidine PET\/CT on gross tumor volume identification and definition for pancreatic cancer","volume":"8","author":"Pretz","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0110","doi-asserted-by":"crossref","first-page":"15850","DOI":"10.1073\/pnas.1506542112","article-title":"Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET\/NIRF imaging of pancreatic cancer","volume":"112","author":"Houghton","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0111","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jss.2011.03.065","article-title":"Anti-CA19-9 diabody as a PET imaging probe for pancreas cancer","volume":"170","author":"Girgis","year":"2011","journal-title":"J Surg Res"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0112","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1158\/1078-0432.CCR-18-3667","article-title":"Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer","volume":"25","author":"Lohrmann","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0113","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1021\/acs.molpharmaceut.6b01130","article-title":"Preloading with Unlabeled CA19.9 Targeted Human Monoclonal Antibody Leads to Improved PET Imaging with 89Zr-5B1","volume":"14","author":"Houghton","year":"2017","journal-title":"Molecular Pharmaceutics"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0114","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1158\/1078-0432.CCR-18-3667","article-title":"Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer","volume":"25","author":"Lohrmann","year":"2019","journal-title":"Clinical Cancer Research"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2967\/jnumed.113.129619","article-title":"Multimodal Molecular Imaging of Integrin \u03b1v\u03b23 for In Vivo Detection of Pancreatic Cancer","volume":"55","author":"Trajkovic-Arsic","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0116","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s00259-015-3096-4","article-title":"Biodistribution of the 18F-FPPRGD2 PET radiopharmaceutical in cancer patients: An atlas of SUV measurements","volume":"42","author":"Minamimoto","year":"2015","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0117","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiol.2015141550","article-title":"Glioblastoma Multiforme Recurrence: An Exploratory Study of 18F FPPRGD2 PET\/CT","volume":"277","author":"Iagaru","year":"2015","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0118","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00259-015-3263-7","article-title":"Pilot prospective evaluation of 18F-FPPRGD2 PET\/CT in patients with cervical and ovarian cancer","volume":"43","author":"Minamimoto","year":"2016","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0119","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/cbr.2011.1061","article-title":"Whole-Body Distribution and Radiation Dosimetry of 68Ga-NOTA-RGD, a Positron Emission Tomography Agent for Angiogenesis Imaging","volume":"27","year":"2012","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0120","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2967\/jnumed.111.088955","article-title":"Biodistribution and Radiation Dosimetry of the Integrin Marker 18F-RGD-K5 Determined from Whole-Body PET\/CT in Monkeys and Humans","volume":"53","author":"Doss","year":"2012","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0121","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00259-015-3118-2","article-title":"18\u2009F-Alfatide II PET\/CT in healthy human volunteers and patients with brain metastases","volume":"42","author":"Yu","year":"2015","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0122","series-title":"Defining the role of integrin alphavbeta6 in cancer","author":"Bandyopadhyay","year":"2009"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0123","series-title":"Molecular imaging of integrin alphavbeta6 expression in living subjects","author":"Liu","year":"2014"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0124","series-title":"Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling","author":"Breuss","year":"1995"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0125","series-title":"Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro","author":"Sipos","year":"2004"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0126","series-title":"Expression of alpha V-associated integrin beta subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens","author":"Maubant","year":"2005"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0127","series-title":"High numbers of human skin cancers express MMP2 and several integrin genes","author":"Orimoto","year":"2008"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0128","series-title":"Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma","author":"Bates","year":"2005"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0129","series-title":"A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer","author":"Elayadi","year":"2007"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0130","series-title":"Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival","author":"Hazelbag","year":"2007"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0131","series-title":"Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma","author":"Zhang","year":"2008"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0132","series-title":"Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver","author":"Yang","year":"2008"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0133","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1038\/s41467-019-11863-w","article-title":"Evaluation of integrin \u03b1v\u03b26 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis","volume":"10","author":"Kimura","year":"2019","journal-title":"Nature Communications"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0134","article-title":"Clinical quantification of the integrin \u03b1v\u03b26 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)","author":"Lukey","year":"2019","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0135","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1078-0432.CCR-18-2665","article-title":"Preclinical Development and First-in-Human Imaging of the Integrin \u03b1v\u03b26 with [18F]\u03b1v\u03b26-Binding Peptide in Metastatic Carcinoma","volume":"25","author":"Hausner","year":"2019","journal-title":"Clinical Cancer Research"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0136","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0137","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0138","article-title":"Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients","author":"Meyer","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0139","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00268-009-0249-2","article-title":"Incidental gallbladder cancer diagnosed following laparoscopic cholecystectomy","volume":"33","author":"Choi","year":"2009","journal-title":"World J Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cpet.2015.03.001","article-title":"FDG PET\/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes","volume":"10","author":"Parikh","year":"2015","journal-title":"PET Clin"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0141","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jso.23476","article-title":"Ability of FDG-PET\/CT in the detection of gallbladder cancer","volume":"109","author":"Ramos-Font","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0142","doi-asserted-by":"crossref","first-page":"11481","DOI":"10.3748\/wjg.v21.i40.11481","article-title":"Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis","volume":"21","author":"Annunziata","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0143","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prp.2009.07.018","article-title":"Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract","volume":"206","author":"Sung","year":"2010","journal-title":"Pathol Res Pract"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0144","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3349\/ymj.2019.60.7.604","article-title":"Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using (1)(8)F-FDG PET\/CT in Locally Advanced and Metastatic Gallbladder Carcinoma","volume":"60","author":"Chun","year":"2019","journal-title":"Yonsei Med J"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12029-010-9221-5","article-title":"Successful diagnosis of gallbladder carcinoma coexisting with adenomyomatosis by 18F-FDG-PET\u2013report of a case","volume":"42","author":"Suzuki","year":"2011","journal-title":"J Gastrointest Cancer"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0146","doi-asserted-by":"crossref","first-page":"901-906","DOI":"10.1007\/s12029-018-0176-2","article-title":"Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening","volume":"50","author":"Gupta","year":"2019","journal-title":"J Gastrointest Cancer"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0147","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2967\/jnumed.111.093948","article-title":"Risk stratification of gallbladder polyps (1-2 cm) for surgical intervention with 18F-FDG PET\/CT","volume":"53","author":"Lee","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0148","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1007\/s00330-017-4742-y","volume":"27","author":"Wiles","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0149","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1477-2574.2009.00104.x","article-title":"The role of PET-CT in patients with incidental gallbladder cancer","volume":"11","author":"Butte","year":"2009","journal-title":"HPB (Oxford)"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0150","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jso.20533","article-title":"Application of modern imaging methods in diagnosis of gallbladder cancer","volume":"93","author":"Rodriguez-Fernandez","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0151","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/RLU.0b013e31824d24c4","article-title":"Role of 18F-FDG PET\/CT in detecting recurrent gallbladder carcinoma","volume":"37","author":"Kumar","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0152","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","article-title":"18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer","volume":"206","author":"Corvera","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0153","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13139-014-0294-0","article-title":"Late Port Site Metastasis from Occult Gall Bladder Carcinoma After Laparoscopic Cholecystectomy for Cholelithiasis: The Role of (18)F-FDG PET\/CT","volume":"48","author":"Sharma","year":"2014","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2020.04.002_bib0154","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1470-2045(09)70333-X","article-title":"Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: A phase 2 study","volume":"11","author":"Zhu","year":"2010","journal-title":"Lancet Oncol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299820300519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299820300519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:36:07Z","timestamp":1757543767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299820300519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":154,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0001299820300519"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.04.002","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}